Winston Medical Supply Co., Ltd. (TPEX:6817)

Market Cap	806.66M -60.0%
Revenue (ttm)	632.80M -12.6%
Net Income	82.47M -38.6%
EPS	4.47 -38.4%
Shares Out	18.42M
PE Ratio	9.79
Forward PE	n/a
Dividend	5.00 (10.91%)
Ex-Dividend Date	Jun 16, 2026

Volume	41,269
Open	42.10
Previous Close	44.10
Day's Range	40.15 - 43.85
52-Week Range	42.00 - 114.00
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Winston Medical Supply

Winston Medical Supply Co., Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, ch...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1974
• Employees: 180
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6817

Financial Performance

In 2025, Winston Medical Supply's revenue was 700.07 million, an increase of 0.72% compared to the previous year's 695.08 million. Earnings were 117.29 million, a decrease of -10.87%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 8, 2026

Data Sources Report a data error